Cambridge Investment Research Advisors’s Gildan GIL Stock Holding History

Cambridge Investment Research Advisors’s Portfolio GIL Stock Details GIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$343K	Sell	6,165 -736	-11%	-$47.6K	﹤0.01%	3162
2025 Q4	$431K	Buy	+6,901	New	+$410K	﹤0.01%	2865
2024 Q3	–	Sell	-9,814	Closed	-$372K	–	3459
2024 Q2	$372K	Sell	9,814 -263	-3%	-$9.51K	﹤0.01%	2535
2024 Q1	$374K	Sell	10,077 -685	-6%	-$23.3K	﹤0.01%	2528
2023 Q4	$356K	Buy	+10,762	New	+$349K	﹤0.01%	2467
2017 Q1	–	Sell	-11,767	Closed	-$299K	–	1783
2016 Q4	$299K	Sell	11,767 -504	-4%	-$13.4K	0.01%	1269
2016 Q3	$343K	Sell	12,271 -774	-6%	-$22.9K	0.01%	1227
2016 Q2	$383K	Buy	13,045 +1,871	+17%	+$55.8K	0.01%	1070
2016 Q1	$341K	Buy	+11,174	New	+$297K	0.01%	1105
2015 Q3	–	Sell	-15,813	Closed	-$526K	–	1522
2015 Q2	$526K	Buy	+15,813	New	+$507K	0.01%	791

Other funds holding GIL

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cambridge Investment Research Advisors's GIL Position: Q1 2026 in Review

Cambridge Investment Research Advisors reduced its Gildan (GIL) stake by 11% in Q1 2026, selling an estimated $47.6K and leaving 6,165 shares worth $343K. The position accounts for ﹤0.01% of the portfolio, ranked #3162.

Cambridge Investment Research Advisors first reported a position in GIL in Q2 2015 and has held it in 10 quarters since. The position peaked at $526K in Q2 2015. 482 funds tracked by Wall St. Rank hold GIL as of Q1 2026.

Cambridge Investment Research Advisors held 6,165 shares of Gildan worth $343K as of Q1 2026.
Cambridge Investment Research Advisors sold 736 Gildan shares in Q1 2026, an estimated $47.6K.
Gildan made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #3162 holding.
Cambridge Investment Research Advisors first reported a position in Gildan in Q2 2015 and has held it in 10 quarters since.
Cambridge Investment Research Advisors's Gildan position peaked at $526K in Q2 2015.
482 funds tracked by Wall St. Rank held Gildan as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.